REDWOOD CITY, Calif., Feb. 04, 2016 -- Cardica, Inc. (Nasdaq:CRDC) today announced that Julian Nikolchev, the company’s president and CEO, with give a corporate overview and update at Source Capital’s 2016 Disruptive Growth and Healthcare Conference on Wednesday, February 10, 2016 at 4:00pm Eastern Time in New York City.
For more information on the conference, or for investor registration, please go to www.SourceCapitalConference.com. To access the live and subsequently archived webcast of the presentation, go to the Investor Relations section of the company's website at http://www.cardica.com. Please connect to the website at least 15 minutes prior to the presentation to allow for any necessary software downloads.
About Source Capital Group
Source Capital Group, Inc. was founded in 1992 on the belief that the best investment advice should be independent, unbiased and tailor-made for the individual client’s needs. Source Capital began as a boutique investment banking firm specializing in small to medium sized transactions. We have grown to include businesses in general securities, emerging market securities, distressed and high yield debt securities, in addition to our investment banking activity. http://www.sourcegrp.com/
About Cardica
Cardica designs and manufactures proprietary stapling and anastomotic devices for cardiac and minimally invasive surgical procedures. Cardica's technology portfolio is intended to reduce operating time and facilitate minimally invasive and robot-assisted surgeries. Cardica’s MicroCutter XCHANGE® 30, that includes a cartridge-based articulating surgical stapling device with a five-millimeter shaft diameter and staples, is manufactured and cleared for use in the United States for transection and resection in multiple open or minimally invasive urologic, thoracic and pediatric surgical procedures, as well as application for transection, resection and/or creation of anastomoses in the small and large intestine and the transection of the appendix. The MicroCutter XCHANGE 30 white cartridge staple has application in vascular tissue. In addition, Cardica manufactures and markets its automated anastomosis systems, the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System for coronary artery bypass graft (CABG) surgery, and has shipped over 57,500 units throughout the world.
Contact: Bob Newell Vice President, Finance and Chief Financial Officer (650) 331-7133 [email protected]


Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand 



